PAPER
Synthesis of an Orthogonally Protected Glucosamine
489
Phenyl 3,4,6-Tri-O-acetyl-2-deoxy-2-phthalimido-1-thio- -D-
glucopyranoside (2)
Phenyl 3-O-(tert-Butyldimethylsilyl)-4,6-O-(p-methoxybenzyl-
idene)-2-deoxy-2-phthalimido-1-thio- -D-glucopyranoside (5)
Anisylidene acetal 4 (1.5 g, 2.9 mmol) was dissolved in anhyd
CH2Cl2 (10 mL) in an oven-dried 25 mL round-bottomed flask.
Et3N (0.69 mL, 4.9 mmol) was added and the reaction mixture was
stirred for 10 min at r.t., under argon. AgNO3 (0.74 g, 4.3 mmol)
was added and the reaction flask was covered with aluminum foil
(to prevent photoactivated degradation) and stirred for 15 min, then
treated with tert-butyldimethylchlorosilane (TBSCl, 0.66 g, 4.3
mmol). A white precipitate of AgCl was observed immediately. The
mixture was stirred at r.t. for 18 h, then filtered through Celite into
a sat. aq solution of NaHCO3 (10 mL). The aqueous phase was sep-
arated and extracted with additional CH2Cl2 (2 7 mL). The com-
bined organic phases were then washed with brine (7 mL), dried
(Na2SO4), and concentrated by rotary evaporation. The crude prod-
uct was dissolved in a minimum amount of hot EtOAc (5 mL), then
diluted with hexanes (20 mL) and cooled to 0 °C overnight. The re-
crystallized product was collected by filtration, washed with cold
10% EtOAc in hexanes and dried to yield the desired compound 5
as white crystals (1.62 g, 88%); mp 176.0 0.5 °C; [ ]D +26.8 (c =
0.81, CHCl3).
An oven-dried 1 L round-bottomed flask was charged with tetraac-
etate 1 (43.25 g, 90.9 mmol), thiophenol (Aldrich, 28 mL, 272.8
mmol), and anhyd CH2Cl2 (430 mL). The mixture was treated with
freshly distilled TMSOTf (20 mL, 109.2 mmol) at r.t. and stirred for
7 h under argon. The mixture was then quenched with a sat. aq so-
lution of NaHCO3 (400 mL) and separated. The aqueous layer was
extracted with additional CH2Cl2 (2 100 mL); the combined or-
ganic phases were then washed with brine (250 mL), dried
(Na2SO4), and concentrated by rotary evaporation equipped with a
bleach trap. The crude product was dissolved in a minimum amount
of hot EtOAc (65 mL), then diluted with hexanes (200 mL) and
cooled to 0 °C. The recrystallized product was collected by filtra-
tion, washed with cold 10% EtOAc in hexanes, and dried to yield
the desired thiophenyl glycoside 2 (36.5 g, 76%). Comparison of the
1H NMR signals (CDCl3, 300 MHz) with the values in the
literature19 confirmed the identity of 2; mp 145.0 0.5 °C.
Phenyl 4,6-O-(p-Methoxybenzylidene)-2-deoxy-2-phthalimido-
1-thio- -D-glucopyranoside (4)
To a 100 mL round-bottomed flask was added the triacetate 2 (8.5
g, 16.1 mmol) and a 3:2 mixture of MeOH–CH2Cl2 (Mallinckrodt,
80.0 mL). The mixture was cooled to –20 °C, treated with a 0.3 M
NaOMe solution in MeOH (21.3 mL, 6.4 mmol) and stirred for 10
min, then warmed to –10 °C and stirred for 2 h. The reaction mix-
ture was warmed to 0 ºC and passed through an ion-exchange resin
(Dowex 50WX8-100) packed with MeOH. The crude triol was con-
centrated by rotary evaporation and dried under vacuum overnight
in a 250 mL round-bottomed flask, then suspended in anhyd toluene
(Mallinckrodt, 80 mL). p-Anisaldehyde dimethyl acetal (Avocado,
3.3 mL, 19.4 mmol) and camphorsulfonic acid (0.86 g, 3.7 mmol)
were also added and the mixture was stirred at 90 °C for 3 h in a
flask equipped with a Dean–Stark apparatus. The temperature was
increased to 120 °C and refluxed until 2 mL of MeOH–toluene
azeotrope had been collected, then cooled to r.t. The mixture was
quenched with a sat. aq solution of NaHCO3 (100 mL) and diluted
with EtOAc (60 mL). The aqueous layer was separated and extract-
ed with additional EtOAc (2 50 mL). The combined organic phas-
es were then washed with brine (50 mL), dried (Na2SO4), and
concentrated by rotary evaporation. The product was purified by sil-
ica gel chromatography using a 10–50% EtOAc–hexanes gradient
to yield the desired anisylidene acetal 4 as a white solid (6.75 g,
80% overall yield); mp 182.0 0.5 °C; [ ]D +32.9 (c = 1.02,
CHCl3).
IR (film): 1772, 1711, 1617, 1515, 1472, 1385, 1247, 1171, 1142,
1117, 1092, 856, 722 cm–1.
1H NMR (300 MHz, CDCl3): = 7.73–7.88 (m, 4 H, ArH), 7.23–
7.41 (m, 7 H, ArH), 6.89 (d, 2 H, J = 8.7 Hz, ArH), 5.67 (d, 1 H,
J = 10.7 Hz, H-1), 5.48 (s, 1 H, CHPMP), 4.63 (t, 1 H, J = 9.3 Hz,
H-3), 4.37 (dd, 1 H, J = 4.4, 9.9 Hz, H-6a), 4.32 (t, 1 H, J = 9.9 Hz,
H-2), 3.77–3.83 (m, 4 H, H-6e, OCH3), 3.71 (ddd, 1 H, J = 4.4, 9.2,
9.8 Hz, H-5), 3.56 (t, 1 H, J = 8.9 Hz, H-4), 0.57 [s, 9 H,
C(CH3)3], –0.14 (s, 3 H, SiCH3), –0.30 (s, 3 H, SiCH3).
13C NMR (75 MHz, CDCl3): = 160.05 (1 C, Carom–OCH3), 134.22,
132.28, 132.14, 131.68, 129.59, 128.90, 127.88, 127.64, 123.61,
123.22, 113.46 (17 C, C and CH arom), 101.89 (1C, Cacetal), 84.37
(1C, C-1), 82.39, 70.66, 70.58, 68.60, 56.66, 55.21 (6 C, C-
2,3,4,5,6, OCH3), 25.36 [3 C, C(CH3)3], 17.69 [1 C, C(CH3)3], –4.16
(1 C, SiCH3), –5.39 (1 C, SiCH3).
ESI-MS: m/z = 634 (M + H).
Anal. Calcd for C34H39NO7SSi: C, 64.43; H, 6.20; N, 2.21. Found:
C, 64.28; H, 6.15; N, 2.19.
Phenyl 3-O-(tert-Butyldimethylsilyl)-4-O-(p-methoxybenzyl)-2-
deoxy-2-phthalimido-1-thio- -D-glucopyranoside (6)
Compound 5 (151 mg, 0.24 mmol) was dissolved in anhyd CH2Cl2
(1.0 mL) in an oven-dried 25 mL round-bottomed flask. The reac-
tion mixture was cooled to –20 °C under argon and treated with bo-
rane–THF (2.4 mL of a 1 M solution in THF). The mixture was
stirred at –20 °C for 15 min, then treated with TMSOTf (0.07 mL of
a 2 M solution in CH2Cl2) and warmed to 0 °C over a period of 30
min. The mixture was stirred at 0 °C for an additional 4 h, cooled to
–15 °C and treated with Et3N (0.2 mL), then quenched by the drop-
wise addition of MeOH (3 mL) until effervescence ceased. The
mixture was warmed to r.t. and concentrated by rotary evaporation
to dryness. The product was purified by silica gel chromatography
using a 20–40% EtOAc–hexanes gradient to yield the desired O-6
alcohol 6 as a white crystalline solid (145 mg, 96%); mp 166.0 0.5
°C; [ ]D +48.0 (c = 1.03, CHCl3).
IR (film): 3474, 1774, 1713, 1614, 1519, 1387, 1250, 1091, 752,
720, 688 cm–1.
1H NMR (300 MHz, CDCl3): = 7.73–7.89 (m, 4 H, ArH), 7.36–
7.42 (m, 7 H, ArH), 6.90 (d, 2 H, J = 8.7 Hz, ArH), 5.70 (d, 1 H,
J = 10.5 Hz, H-1), 5.52 (s, 1 H, CH-PMP), 4.65 (dd, 1 H, J = 2.9,
9.8 Hz, H-3), 4.39 (dd, 1 H, J = 4.6, 10.2 Hz, H-6a), 4.32 (t, 1 H,
J = 10.2 Hz, H-2), 3.77–3.84 (m, 4 H, H-6e, OCH3), 3.70 (ddd, 1 H,
J = 4.5, 9.3, 9.8 Hz, H-5), 3.58 (t, 1 H, J = 9.0 Hz, H-4), 2.54 (d,
1 H, J = 3.3 Hz, OH).
13C NMR (75 MHz, CDCl3): = 160.29 (1 C, Carom–OCH3), 134.20,
132.59, 131.78, 131.57, 129.34, 128.93, 128.07, 127.62, 123.81,
123.34, 113.72 (17 C, C and CH arom), 101.86 (1 C, Cacetal), 84.25
(1 C, C-1), 81.81, 70.27, 69.68, 68.51, 55.49, 55.28 (6 C, C-
2,3,4,5,6, OCH3).
IR (film): 3479, 1776, 1711, 1613, 1514, 1387, 1249, 1109, 1087,
1034, 838, 754, 720 cm–1.
ESI-MS: m/z = 520 (M + H).
1H NMR (300 MHz, CDCl3): = 7.69–7.82 (m, 4 H, ArH), 7.18–
7.31 (m, 7 H, ArH), 6.84 (d, 2 H, J = 8.54 Hz, ArH), 5.61 (d, 1 H,
J = 10.5 Hz, H1), 4.74 (d, 1 H, J = 11.3 Hz, benzyl-H), 4.55 (d, 1 H,
J = 11.4 Hz, benzyl-H), 4.45 (t, 1 H, J = 9.5 Hz, H-3), 4.21 (t, 1 H,
J = 10.2 Hz, H-2), 3.80–3.86 (m, 1 H, H-6a), 3.75 (s, 3 H, OCH3),
3.59–3.67 (m, 1 H, H-5), 3.50–3.58 (m, 1 H, H-6e), 3.46 (t, 1 H,
Anal. Calcd for C28H25NO7S: C, 64.73; H, 4.85; N, 2.70. Found: C,
64.68; H, 4.88; N, 2.64.
Synthesis 2002, No. 4, 487–490 ISSN 0039-7881 © Thieme Stuttgart · New York